# Program 1 Phase X - Readiness Gate Review and Non-Production Continuity Decision

Status: documentation-only readiness gate review. Not a readiness approval.

## Purpose

Phase X reviews accumulated Program 1 governance, planning, prototype, and validation-harness documentation through Phase W and records a non-production continuity decision.

Phase X keeps Program 1 in non-production status. It does not approve production use, real patient data, PHI/PII processing, clinical deployment, autonomous diagnosis or treatment, clinical write workflows, patient communication, appointment status mutation, workflow enforcement, or runtime approval/override/clearance behavior.

## Scope

- Review Program 1 phase history through Phase W.
- Define documentation/governance readiness gate criteria.
- Record gate result as blocked for production-readiness claims.
- Confirm negative tests and validation harness outputs remain passive and non-production.
- Record a non-production continuity decision.

## Non-scope

Phase X does not add runtime code, tests, helpers, scripts, imports, services, migrations, API endpoints, UI flows, auth/authz/RBAC runtime behavior, audit logging runtime behavior, clinical write workflows, Task engine, Outcome Evidence, patient messaging, appointment mutation, workflow enforcement, approval/clearance/override capability, production deployment behavior, or go-live authorization.

## Safety boundaries

Program 1 remains not cleared for:

- production use
- real patient data
- PHI/PII processing
- clinical deployment
- autonomous diagnosis or treatment
- clinical write workflows
- patient communication
- appointment status mutation
- workflow enforcement
- runtime approval/override/clearance behavior

## Prior phase review

- Phase K documented Pilot Demo RC1 remote/tag verification.
- Phase L documented production-readiness gaps.
- Phase M converted gaps into remediation planning.
- Phase N designed governance controls.
- Phase O designed real patient data governance.
- Phase P designed access control and auditability.
- Phase Q designed validation and safety testing.
- Phase R designed operational readiness and incident response planning.
- Phase S planned governance control implementation.
- Phase T created implementation ticketing packages.
- Phase U strengthened static governance and non-approval controls.
- Phase V documented access, audit, and real-data boundary prototypes.
- Phase W documented validation harness and negative test implementation expectations.

## Readiness gate criteria

The Phase X gate criteria are documentation/governance criteria only. They ask whether the project has documented boundaries, blockers, non-approval language, phase history, and future evidence needs. They do not approve runtime behavior.

## Readiness gate result

Result: blocked for production-readiness claims.

The blockers remain unresolved. Phase X confirms continuity in non-production status rather than readiness approval.

## Non-production continuity decision

Decision: Program 1 continues as a demo/governance/read-only/non-production foundation. Future work may continue documenting and prototyping controls only when explicit no-go boundaries remain active.

## Explicit non-approval statement

Phase X is a review, not approval. Phase X does not certify, clear, validate, deploy, operationally approve, or authorize clinical use.

## Next-step decision

Recommended next step: `Program 1 Phase Y0 - Integrated Non-Production Control Validation`.

## Closure statement

Phase X closes with Program 1 still blocked from production-readiness, real-data, PHI/PII, clinical deployment, go-live, clinical write, messaging, appointment mutation, workflow enforcement, and runtime approval/override/clearance claims.
